Morphology, molecular regulation and significance of apoptosis in pituitary adenomas

被引:0
|
作者
Kapranos, N
Kontogeorgos, G
Horvath, E
Kovacs, K
机构
[1] G Genimatas Athens Gen Hosp, Dept Pathol, GR-11527 Athens, Greece
[2] G Genimatas Athens Gen Hosp, Mitera Matern & Surg Ctr, Dept Mol Pathol, GR-11527 Athens, Greece
[3] Univ Toronto, St Michaels Hosp, Dept Pathol, Toronto, ON, Canada
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apoptosis represents energy-requiring spontaneous single cell death, with specific morphologic and biochemical features. It is a rapidly processed sequence of events resulting in elimination of damaged cells. Apoptosis occurs in physiological remodeling and proliferative conditions, and also in neoplastic lesions. Several molecules and molecular systems such as bet-2/bax, Fas/FasL and caspases regulate the apoptotic process. Apoptosis is characterized by a stereotypic pattern of morphologic features, which can be illustrated mostly by electron microscopy. DNA and biochemical assays, based on the specific pattern of nucleosomal fragmentation can detect apoptosis. The in situ labeling techniques are currently used to demonstrate apoptosis in paraffin sections. Several studies of pituitary animal models, cell lines and human pituitaries have been performed during the last 6 years. By electron microscopy, pituitary adenoma cells undergoing apoptosis exhibit a common prototypical pathway of changes. Although the results by the situ labeling techniques are not uniform, apoptosis occurs with low frequency in a subset of pituitary adenomas, ill carcinomas and in pituitary hyperplasia. Alternative techniques based on remodeling of cytoskeleton by caspase activity can identify early apoptotic stages. This review presents the principles of apoptosis and summarizes the morphologic and functional changes of apoptosis in pituitary. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:217 / 234
页数:18
相关论文
共 50 条
  • [31] EFFECTS OF OCTREOTIDE ON MORPHOLOGY OF PITUITARY-ADENOMAS IN ACROMEGALY
    SAUTNER, D
    SAEGER, W
    TALLEN, G
    LUDECKE, DK
    REHPENNING, W
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1993, 189 (09) : 1044 - 1051
  • [32] EFFECTS OF DRUGS ON THE MORPHOLOGY OF HUMAN PITUITARY-ADENOMAS
    KOVACS, K
    HORVATH, E
    STEFANEAU, L
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 33 - CHAS
  • [33] Editorial: Molecular Network Study of Pituitary Adenomas
    Zhan, Xianquan
    Desiderio, Dominic M.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [34] Molecular genetics and new classification of pituitary adenomas
    Assie, G.
    Villa, C.
    Baussart, B.
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2022, 206 (07): : 831 - 836
  • [35] Recent advancements in the molecular biology of pituitary adenomas
    Zheng, Allison C.
    Wang, Elaina J.
    Aghi, Manish K.
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (04) : 293 - 304
  • [36] Molecular pathogenesis of pituitary adenomas: A review - Comments
    de Tribolet, N
    Gomez, F
    [J]. ACTA NEUROCHIRURGICA, 1999, 141 (07) : 736 - 736
  • [37] Clinical aspects of molecular biology of pituitary adenomas
    Larysz, Dawid
    Blamek, Stawomir
    Rudnik, Adam
    [J]. FOLIA NEUROPATHOLOGICA, 2012, 50 (02) : 110 - 117
  • [38] Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas
    Anat Ben-Shlomo
    Ning-Ai Liu
    Shlomo Melmed
    [J]. Pituitary, 2017, 20 : 93 - 99
  • [39] Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas
    Ben-Shlomo, Anat
    Liu, Ning-Ai
    Melmed, Shlomo
    [J]. PITUITARY, 2017, 20 (01) : 93 - 99
  • [40] THE SIGNIFICANCE OF IMMUNOHISTOCHEMISTRY IN THE POSTOPERATIVE EVALUATION OF PATIENTS WITH PITUITARY-ADENOMAS
    SCHATZ, H
    LEICHT, R
    SCHRODER, O
    STRACKE, H
    GROTE, E
    FEDERLIN, K
    [J]. ACTA ENDOCRINOLOGICA, 1982, 99 : 160 - 161